Thus, the aim of this study was to determine whether intracerebroventricular (i.c.v.)administration of Ang-(1-7) can modulate systemic inflammation through the activation of humoral pathways in late phase of endotoxemia. Here, ANG is linked to serum lipopolysaccharide activity.